Abbott Laboratories (Pakistan) Limited (PSX:ABOT)

PSX:ABOT Income Statement

Financials in millions PKR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	74,840	68,177	55,475	49,258	42,570	35,283
Revenue Growth (YoY)	17.28%	22.90%	12.62%	15.71%	20.65%	17.00%
Cost of Revenue	49,676	48,283	43,715	34,821	26,554	23,499
Gross Profit	25,164	19,894	11,760	14,436	16,015	11,784
Selling, General & Admin	11,858	10,362	8,989	7,835	7,232	5,516
Other Operating Expenses	1,376	862.48	303.19	590.58	777.55	602.55
Operating Expenses	13,234	11,225	9,292	8,425	8,009	6,119
Operating Income	11,930	8,669	2,468	6,011	8,006	5,666
Interest Expense	-48.52	-11.74	-22.18	-25.41	-54.48	-70.39
Interest & Investment Income	640.2	621.67	893.59	995.1	571.13	344.36
Currency Exchange Gain (Loss)	-196.59	-16.2	-1,341	-779.79	-240.34	-105.83
Other Non Operating Income (Expenses)	46.98	58.55	71.27	41.08	108.9	150.21
EBT Excluding Unusual Items	12,372	9,321	2,069	6,242	8,392	5,984
Gain (Loss) on Sale of Assets	102.62	31.14	20.26	-94.33	18.92	4.16
Asset Writedown	-225.04	-225.04	-	-	-	-
Other Unusual Items	-	-	500.05	-	-	255.46
Pretax Income	12,249	9,128	2,590	6,148	8,410	6,244
Income Tax Expense	5,599	3,893	2,328	3,143	2,443	1,708
Net Income	6,651	5,234	261.78	3,004	5,967	4,535
Net Income to Common	6,651	5,234	261.78	3,004	5,967	4,535
Net Income Growth	32.91%	1899.50%	-91.29%	-49.65%	31.57%	248.90%
Shares Outstanding (Basic)	98	98	98	98	98	98
Shares Outstanding (Diluted)	98	98	98	98	98	98
EPS (Basic)	67.93	53.46	2.67	30.69	60.95	46.33
EPS (Diluted)	67.93	53.46	2.67	30.69	60.95	46.33
EPS Growth	32.95%	1899.50%	-91.29%	-49.65%	31.57%	248.90%
Free Cash Flow	5,246	1,652	-3,137	212.23	5,768	6,768
Free Cash Flow Per Share	53.58	16.87	-32.04	2.17	58.92	69.13
Dividend Per Share	10.000	10.000	-	15.000	40.000	40.000
Dividend Growth	-	-	-	-62.50%	-	433.33%
Gross Margin	33.62%	29.18%	21.20%	29.31%	37.62%	33.40%
Operating Margin	15.94%	12.72%	4.45%	12.20%	18.81%	16.06%
Profit Margin	8.89%	7.68%	0.47%	6.10%	14.02%	12.85%
Free Cash Flow Margin	7.01%	2.42%	-5.65%	0.43%	13.55%	19.18%
EBITDA	14,048	10,366	3,966	7,368	9,119	6,649
EBITDA Margin	18.77%	15.20%	7.15%	14.96%	21.42%	18.84%
D&A For EBITDA	2,118	1,697	1,498	1,357	1,113	983.72
EBIT	11,930	8,669	2,468	6,011	8,006	5,666
EBIT Margin	15.94%	12.72%	4.45%	12.20%	18.81%	16.06%
Effective Tax Rate	45.71%	42.65%	89.89%	51.13%	29.05%	27.36%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.